UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$205M |
| 2 |
Johnson & Johnson
JNJ
|
+$186M |
| 3 |
Honeywell
HON
|
+$177M |
| 4 |
Mondelez International
MDLZ
|
+$132M |
| 5 |
Alibaba
BABA
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$270M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$212M |
| 3 |
Citigroup
C
|
+$185M |
| 4 |
Booking.com
BKNG
|
+$104M |
| 5 |
Intuitive Surgical
ISRG
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 14.47% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Communication Services | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
201
DELISTED
CATALENT, INC.
CTLT
| $97.8M | 0.11% |
4,252,650
+799,498
| +23% | +$21.1M |
|
202
Eaton
ETN
$150B
| $97M | 0.11% |
1,623,291
+80,111
| +5% | +$4.92M |
|
203
Perrigo
PRGO
$1.43B
| $95.8M | 0.11% |
1,057,143
-52,451
| -5% | -$5.43M |
|
204
Emerson Electric
EMR
$83.3B
| $95.6M | 0.11% |
1,833,330
-415,912
| -18% | -$22.1M |
|
205
Boston Scientific
BSX
$68.4B
| $94.9M | 0.11% |
4,059,898
+1,042,069
| +35% | +$22.5M |
|
206
FedEx
FDX
$73B
| $94.5M | 0.11% |
622,395
-1,830
| -0.3% | -$297K |
|
207
Lexicon Pharmaceuticals
LXRX
$1.04B
| $94.3M | 0.11% |
6,570,712
-651,006
| -9% | -$8.83M |
|
208
Waste Management
WM
$90.9B
| $93.9M | 0.11% |
1,417,295
+54,072
| +4% | +$3.27M |
|
209
Bank of Montreal
BMO
$125B
| $92.5M | 0.1% |
1,465,319
-104,719
| -7% | -$6.64M |
|
210
Baxter International
BAX
$13.8B
| $92.3M | 0.1% |
2,042,142
+316,399
| +18% | +$13.9M |
|
211
Alnylam Pharmaceuticals
ALNY
$27.4B
| $92.3M | 0.1% |
1,662,882
+10,959
| +0.7% | +$690K |
|
212
Best Buy
BBY
$18.5B
| $91.3M | 0.1% |
2,984,578
-100,955
| -3% | -$3.17M |
|
213
T. Rowe Price
TROW
$25.6B
| $91.1M | 0.1% |
1,248,688
+41,009
| +3% | +$3.05M |
|
214
Canadian Imperial Bank of Commerce
CM
$108B
| $90.8M | 0.1% |
2,430,062
+151,524
| +7% | +$5.91M |
|
215
Kroger
KR
$35.4B
| $90.6M | 0.1% |
2,462,926
-112,889
| -4% | -$4.06M |
|
|
YHOO
216
DELISTED
Yahoo Inc
YHOO
| $90M | 0.1% |
2,396,290
+21,794
| +0.9% | +$804K |
|
|
SHPG
217
DELISTED
Shire pic
SHPG
| $90M | 0.1% |
488,672
+197,743
| +68% | +$35.7M |
|
|
TFCFA
218
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $89.4M | 0.1% |
3,305,548
-87,566
| -3% | -$2.55M |
|
|
RHT
219
DELISTED
Red Hat Inc
RHT
| $89.1M | 0.1% |
1,227,214
-294
| -0% | -$22K |
|
220
Ametek
AME
$55B
| $89M | 0.1% |
1,924,778
-1,560,508
| -45% | -$75.1M |
|
221
Cardinal Health
CAH
$53.2B
| $89M | 0.1% |
1,140,415
+71,377
| +7% | +$5.69M |
|
222
Las Vegas Sands
LVS
$32.3B
| $88.7M | 0.1% |
2,039,239
+1,143,077
| +128% | +$53.4M |
|
223
Healthpeak Properties
DOC
$15.2B
| $88.6M | 0.1% |
2,748,411
-119,657
| -4% | -$3.72M |
|
|
VMW
224
DELISTED
VMware, Inc
VMW
| $88.5M | 0.1% |
1,547,352
-1,062,083
| -41% | -$61.2M |
|
225
JD.com
JD
$43.6B
| $87.9M | 0.1% |
4,142,256
+897,913
| +28% | +$21.7M |
|
Similar funds
UBS AM's Q2 2016 Portfolio in Review
As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
- UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
- UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
- UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
- UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
- UBS AM opened 65 new positions and closed 89 in Q2 2016.
- UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.
Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.